ISSN 2149-2263 | E-ISSN 2149-2271
Antithrombotics (Antithrombin therapy) [Anatol J Cardiol]
Anatol J Cardiol. 2006; 6(Suppl 1): 20-24

Antithrombotics (Antithrombin therapy)

Serdar Payzin1
Ege Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, İzmir, Türkiye

Thrombus on the atherosclerotic plaque is mainly responsible for acute coronary syndromes. Antithrombin therapy continues to be the mainstay of the therapy defeating thrombus. Up-to-date antithrombin therapy consists of vitamin K antagonists, unfractionated and low molecular heparins, direct thrombin inhibitors and selective inhibitors of factor Xa. Today, none of these drugs is effective enough in every aspect. The need for new antithrombin drugs, as well as the need for new antiplatelet drugs which can be safely and effectively used to- gether with other antithrombin drugs, persists.

Keywords: Acute coronary syndrome, thrombus, antithrombin therapy

Serdar Payzin. Antithrombotics (Antithrombin therapy). Anatol J Cardiol. 2006; 6(Suppl 1): 20-24
Manuscript Language: English

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2023 The Anatolian Journal of Cardiology

Kare Publishing is a subsidiary of Kare Media.